Skip to nav Skip to content

Read about new research discoveries, treatment advances and more. Moffitt NewsTM brings you the latest information.

52 Stories Found

Moffitt Cancer Center Breaks Ground on New Hospital

The $400 million, 498,000-square-foot facility will serve as an inpatient surgical hospital for Florida’s growing cancer population

Moffitt Cancer Center at Magnolia

Elizabeth Lindsay-Wood Joins Moffitt Cancer Center as Chief Information Officer

Lindsay-Wood will oversee Moffitt’s IT infrastructure, clinical informatics, cybersecurity and IT applications throughout the enterprise.

Moffitt Cancer Center Study Suggests More Could Benefit from CAR T-Cell Therapy

The largest report of commercial CAR T therapy for lymphoma demonstrates its effectiveness even in patients that would not have been eligible for...

Moffitt Researchers Develop Model to Predict Prostate Cancer Aggressiveness

The multiscale mathematical model suggests stromal ecology be considered during diagnosis

Moffitt Cancer Center Names New Clinical Science Research Leaders

Drs. Eric Haura and Nikhil Khushalani will guide the cancer center’s clinical science, clinical trials and expansion

Moffitt Cancer Center Partners with New Blood Banks to Fulfill Growing Needs of Patients

LifeSouth Community Blood Centers and SunCoast Blood Centers will be the cancer center’s new primary and secondary blood suppliers

Moffitt Cancer Center Appoints John Cleveland as New Center Director

John Cleveland, Ph.D., has been named center director and executive vice president of Moffitt Cancer Center, one of 51 National Cancer...

Moffitt Cancer Center Foundation Launches COVID-19 Frontline Response Fund

Donations will support patients and the team members caring for them, as well as virus-related research

Moffitt Researchers Identify Molecular Pathway That Controls Immunosuppression in Tumors

PERK protein controls myeloid-derived suppressor cells immunosuppression and may be an effective therapeutic target

Moffitt Researchers Develop Mathematical Model to Predict Patient Outcomes to Adaptive Prostate Cancer Therapy

The model, based on changing levels of the biomarker PSA, can forecast patient responses to intermittent androgen deprivation therapy

Moffitt Cancer Center Recognized as Tampa Bay Times Top Workplace for 10th Time

The Top Workplaces list includes 100 companies based solely on employee feedback

Moffitt Researchers Identify Novel Therapeutic Targets in Cutaneous Squamous Cell Carcinoma

Delivery of certain microRNAs or targeting AURKA may be effective approaches for treatment

Moffitt Researchers Discover Novel Role of Specific Histone Deacetylase in Non-Small Cell Lung Cancer

Inhibition of HDAC11 blocks cancer stem cell self-renewal and overcomes drug resistance

Moffitt Cancer Center Named a Best and Brightest Company to Work For in The Nation

This is the third time the cancer center has appeared on the list

Augmented Reality Could Put Smoking Cessation in the Palm of Your Hand

Moffitt Cancer Center partners with Haneke Design to develop AR-based app for innovative smoking cessation study